| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurons | 14 | 2017 | 1653 | 1.090 |
Why?
|
| Propylene Glycols | 4 | 2017 | 31 | 1.090 |
Why?
|
| Polyethylene Glycols | 4 | 2017 | 376 | 0.930 |
Why?
|
| Hippocampus | 8 | 2016 | 459 | 0.830 |
Why?
|
| Mitochondria | 7 | 2017 | 621 | 0.620 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2017 | 53 | 0.520 |
Why?
|
| Noninvasive Ventilation | 1 | 2017 | 42 | 0.500 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 6 | 2017 | 58 | 0.460 |
Why?
|
| Infant, Premature | 6 | 2017 | 308 | 0.450 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 2011 | 47 | 0.450 |
Why?
|
| Nitric Oxide | 5 | 2010 | 281 | 0.440 |
Why?
|
| Neuroprotective Agents | 2 | 2008 | 102 | 0.430 |
Why?
|
| Rats | 16 | 2017 | 4154 | 0.360 |
Why?
|
| Poloxamer | 3 | 2018 | 29 | 0.330 |
Why?
|
| Apoptosis | 2 | 2013 | 1756 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2017 | 1267 | 0.290 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2013 | 141 | 0.290 |
Why?
|
| Central Nervous System Diseases | 1 | 2008 | 49 | 0.290 |
Why?
|
| Hypoxia | 4 | 2016 | 681 | 0.280 |
Why?
|
| Infant, Newborn | 9 | 2017 | 2611 | 0.260 |
Why?
|
| Reactive Oxygen Species | 7 | 2013 | 517 | 0.250 |
Why?
|
| Sumoylation | 3 | 2016 | 19 | 0.250 |
Why?
|
| Carotid Artery, Common | 1 | 2006 | 28 | 0.240 |
Why?
|
| Mitochondrial Membranes | 2 | 2017 | 20 | 0.230 |
Why?
|
| Cell Hypoxia | 4 | 2016 | 187 | 0.220 |
Why?
|
| Cells, Cultured | 9 | 2017 | 2929 | 0.220 |
Why?
|
| Pulmonary Artery | 5 | 2013 | 340 | 0.210 |
Why?
|
| Ischemic Attack, Transient | 1 | 2006 | 188 | 0.210 |
Why?
|
| N-Methylaspartate | 2 | 2001 | 50 | 0.210 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2001 | 45 | 0.210 |
Why?
|
| Animals | 25 | 2018 | 28889 | 0.200 |
Why?
|
| Brain Injuries | 1 | 2006 | 171 | 0.200 |
Why?
|
| Synaptic Transmission | 3 | 2010 | 233 | 0.200 |
Why?
|
| Gerbillinae | 2 | 2017 | 12 | 0.190 |
Why?
|
| Cell Survival | 4 | 2017 | 1029 | 0.190 |
Why?
|
| Cell Membrane | 5 | 2018 | 687 | 0.190 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 243 | 0.180 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 2 | 2012 | 17 | 0.180 |
Why?
|
| Patch-Clamp Techniques | 5 | 2016 | 402 | 0.170 |
Why?
|
| Membrane Potentials | 5 | 2013 | 442 | 0.170 |
Why?
|
| Phospholipids | 2 | 2012 | 110 | 0.170 |
Why?
|
| SUMO-1 Protein | 2 | 2011 | 16 | 0.170 |
Why?
|
| Neurotoxins | 1 | 2000 | 48 | 0.170 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 117 | 0.160 |
Why?
|
| Calcium | 6 | 2013 | 1205 | 0.160 |
Why?
|
| Synaptic Vesicles | 2 | 2010 | 40 | 0.160 |
Why?
|
| Animals, Newborn | 1 | 2000 | 536 | 0.150 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 102 | 0.150 |
Why?
|
| Superoxides | 3 | 2013 | 76 | 0.150 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2018 | 35 | 0.140 |
Why?
|
| Developmental Disabilities | 3 | 2010 | 208 | 0.140 |
Why?
|
| Child Development | 2 | 2009 | 174 | 0.130 |
Why?
|
| Mice | 11 | 2018 | 12537 | 0.130 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2016 | 5 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1965 | 0.130 |
Why?
|
| Serum Albumin, Bovine | 1 | 2016 | 47 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 153 | 0.130 |
Why?
|
| Surface-Active Agents | 2 | 2018 | 62 | 0.130 |
Why?
|
| Osteonectin | 1 | 2016 | 22 | 0.130 |
Why?
|
| Palmitic Acid | 1 | 2016 | 29 | 0.130 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 43 | 0.120 |
Why?
|
| Substrate Specificity | 1 | 2017 | 368 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2016 | 50 | 0.120 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2012 | 101 | 0.120 |
Why?
|
| Aging | 1 | 2000 | 766 | 0.120 |
Why?
|
| White Matter | 1 | 2016 | 96 | 0.120 |
Why?
|
| Administration, Inhalation | 4 | 2010 | 203 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 220 | 0.110 |
Why?
|
| Cerebellum | 2 | 2016 | 253 | 0.110 |
Why?
|
| Movement | 1 | 2016 | 324 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2017 | 936 | 0.110 |
Why?
|
| Peroxiredoxins | 1 | 2013 | 14 | 0.100 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2013 | 25 | 0.100 |
Why?
|
| Caspase 1 | 1 | 2013 | 20 | 0.100 |
Why?
|
| Cytochromes c | 1 | 2013 | 28 | 0.100 |
Why?
|
| Caspase Inhibitors | 1 | 2013 | 32 | 0.100 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2013 | 56 | 0.100 |
Why?
|
| Sirtuin 3 | 1 | 2013 | 36 | 0.100 |
Why?
|
| Primary Cell Culture | 1 | 2013 | 83 | 0.100 |
Why?
|
| Oxygen | 2 | 2013 | 781 | 0.100 |
Why?
|
| Electron Transport Complex III | 1 | 2013 | 13 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2016 | 400 | 0.100 |
Why?
|
| Pulmonary Circulation | 1 | 2013 | 92 | 0.090 |
Why?
|
| Male | 11 | 2018 | 45686 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 286 | 0.090 |
Why?
|
| Action Potentials | 1 | 2016 | 618 | 0.090 |
Why?
|
| Liposomes | 1 | 2012 | 99 | 0.090 |
Why?
|
| Fetus | 1 | 2013 | 239 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 314 | 0.090 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 108 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2013 | 692 | 0.090 |
Why?
|
| Nerve Net | 1 | 2016 | 407 | 0.090 |
Why?
|
| Humans | 15 | 2018 | 95802 | 0.090 |
Why?
|
| Dopamine | 2 | 2004 | 283 | 0.090 |
Why?
|
| Shab Potassium Channels | 1 | 2011 | 29 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2013 | 3581 | 0.080 |
Why?
|
| Etomidate | 1 | 2010 | 11 | 0.080 |
Why?
|
| Anesthetics, Intravenous | 1 | 2010 | 43 | 0.080 |
Why?
|
| Unilamellar Liposomes | 1 | 2010 | 5 | 0.080 |
Why?
|
| Propofol | 1 | 2010 | 95 | 0.080 |
Why?
|
| Glucose | 1 | 2013 | 701 | 0.080 |
Why?
|
| Chloride Channels | 2 | 2008 | 43 | 0.080 |
Why?
|
| Infant, Premature, Diseases | 1 | 2010 | 85 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 151 | 0.080 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 95 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 515 | 0.080 |
Why?
|
| Reading | 1 | 2009 | 33 | 0.080 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 381 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2010 | 196 | 0.070 |
Why?
|
| Cricetulus | 3 | 2016 | 132 | 0.070 |
Why?
|
| Isoflurane | 1 | 2009 | 69 | 0.070 |
Why?
|
| CHO Cells | 3 | 2016 | 196 | 0.070 |
Why?
|
| Lung | 3 | 2013 | 1380 | 0.070 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 102 | 0.070 |
Why?
|
| Chloride Channel Agonists | 1 | 2008 | 5 | 0.070 |
Why?
|
| Nervous System | 1 | 2008 | 92 | 0.070 |
Why?
|
| Acidosis | 1 | 2008 | 56 | 0.070 |
Why?
|
| Mutation | 2 | 2018 | 4374 | 0.070 |
Why?
|
| Platelet Activating Factor | 1 | 2008 | 53 | 0.070 |
Why?
|
| Premature Birth | 1 | 2009 | 130 | 0.070 |
Why?
|
| Lipid Peroxidation | 2 | 2012 | 47 | 0.070 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2006 | 90 | 0.060 |
Why?
|
| Pregnancy | 1 | 2013 | 3237 | 0.060 |
Why?
|
| Heart | 1 | 2008 | 590 | 0.060 |
Why?
|
| Barbiturates | 1 | 2005 | 12 | 0.060 |
Why?
|
| Coumarins | 1 | 2005 | 14 | 0.060 |
Why?
|
| Ethanolamines | 1 | 2005 | 24 | 0.060 |
Why?
|
| Risk Factors | 3 | 2011 | 5961 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 362 | 0.060 |
Why?
|
| Functional Laterality | 1 | 2006 | 208 | 0.060 |
Why?
|
| Female | 11 | 2016 | 49872 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2006 | 90 | 0.060 |
Why?
|
| Electrophysiology | 2 | 2008 | 406 | 0.060 |
Why?
|
| Isoxazoles | 1 | 2005 | 78 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2004 | 34 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2004 | 84 | 0.050 |
Why?
|
| Synapses | 1 | 2006 | 291 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2006 | 908 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2008 | 705 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2534 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2006 | 341 | 0.050 |
Why?
|
| Leukomalacia, Periventricular | 3 | 2009 | 19 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2013 | 170 | 0.050 |
Why?
|
| Neuropsychological Tests | 3 | 2009 | 549 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1645 | 0.040 |
Why?
|
| Vasoconstriction | 2 | 2013 | 93 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2005 | 559 | 0.040 |
Why?
|
| Cerebral Palsy | 2 | 2016 | 96 | 0.040 |
Why?
|
| Cell Membrane Structures | 1 | 2001 | 3 | 0.040 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2001 | 7 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2001 | 60 | 0.040 |
Why?
|
| Flavoproteins | 1 | 2001 | 25 | 0.040 |
Why?
|
| Mesencephalon | 1 | 2001 | 69 | 0.040 |
Why?
|
| Cytosol | 2 | 2013 | 197 | 0.040 |
Why?
|
| Cytoprotection | 1 | 2001 | 51 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2000 | 180 | 0.040 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2000 | 11 | 0.040 |
Why?
|
| Necrosis | 1 | 2001 | 210 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2001 | 245 | 0.040 |
Why?
|
| NADH Dehydrogenase | 1 | 2000 | 23 | 0.040 |
Why?
|
| Herbicides | 1 | 2000 | 36 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 796 | 0.040 |
Why?
|
| Pyramidal Cells | 1 | 2000 | 89 | 0.040 |
Why?
|
| Drug Resistance | 1 | 2000 | 234 | 0.040 |
Why?
|
| PC12 Cells | 2 | 2010 | 111 | 0.040 |
Why?
|
| Cricetinae | 2 | 2011 | 542 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 1981 | 0.040 |
Why?
|
| Time Factors | 2 | 2006 | 5561 | 0.040 |
Why?
|
| Parkinson Disease | 1 | 2001 | 178 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2010 | 411 | 0.040 |
Why?
|
| Homeostasis | 1 | 2000 | 467 | 0.030 |
Why?
|
| Models, Neurological | 2 | 2016 | 435 | 0.030 |
Why?
|
| Fluorescent Dyes | 2 | 2010 | 262 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2010 | 3904 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2009 | 3970 | 0.030 |
Why?
|
| Electrophysiological Phenomena | 1 | 2016 | 52 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 70 | 0.030 |
Why?
|
| Birth Weight | 2 | 2009 | 152 | 0.030 |
Why?
|
| Spectrum Analysis | 1 | 2016 | 121 | 0.030 |
Why?
|
| Biophysics | 1 | 2016 | 157 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 213 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2016 | 224 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2013 | 2161 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2016 | 111 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2016 | 397 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2016 | 4664 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2001 | 1275 | 0.030 |
Why?
|
| Child | 3 | 2010 | 7618 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2016 | 382 | 0.030 |
Why?
|
| Biomarkers | 1 | 2000 | 1931 | 0.030 |
Why?
|
| Mitochondria, Muscle | 1 | 2013 | 26 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2013 | 33 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2010 | 1791 | 0.030 |
Why?
|
| Halothane | 1 | 2012 | 13 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 142 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 816 | 0.020 |
Why?
|
| Rotenone | 2 | 2004 | 18 | 0.020 |
Why?
|
| Amidines | 1 | 2012 | 2 | 0.020 |
Why?
|
| Calorimetry | 1 | 2012 | 16 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 3491 | 0.020 |
Why?
|
| Adsorption | 1 | 2012 | 54 | 0.020 |
Why?
|
| Dimerization | 1 | 2012 | 150 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 223 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2012 | 122 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 312 | 0.020 |
Why?
|
| Cell Line | 2 | 2008 | 2536 | 0.020 |
Why?
|
| Potassium | 1 | 2012 | 271 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 329 | 0.020 |
Why?
|
| Light | 1 | 2012 | 297 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 201 | 0.020 |
Why?
|
| Osmosis | 1 | 2010 | 6 | 0.020 |
Why?
|
| Water | 1 | 2012 | 307 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1753 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 2777 | 0.020 |
Why?
|
| Catalase | 1 | 2009 | 49 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2009 | 27 | 0.020 |
Why?
|
| Incidence | 2 | 2005 | 1714 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2009 | 70 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 3360 | 0.020 |
Why?
|
| Lysine | 1 | 2011 | 190 | 0.020 |
Why?
|
| Renal Artery | 1 | 2009 | 46 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1809 | 0.020 |
Why?
|
| Syntaxin 1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cyclobutanes | 1 | 2009 | 8 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2009 | 103 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 220 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2009 | 26 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 172 | 0.020 |
Why?
|
| Social Class | 1 | 2009 | 145 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 443 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2006 | 1662 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchanger 1 | 1 | 2008 | 4 | 0.020 |
Why?
|
| Fura-2 | 1 | 2008 | 22 | 0.020 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2008 | 18 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2008 | 33 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2008 | 65 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 564 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2008 | 78 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2008 | 68 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2008 | 164 | 0.020 |
Why?
|
| Students | 1 | 2009 | 179 | 0.020 |
Why?
|
| ROC Curve | 1 | 2009 | 797 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2008 | 509 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2006 | 14 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 2006 | 14 | 0.020 |
Why?
|
| RNA Interference | 1 | 2008 | 385 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 1008 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 24 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 640 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2006 | 85 | 0.020 |
Why?
|
| Chlorides | 1 | 2006 | 108 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2006 | 159 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 2480 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1176 | 0.010 |
Why?
|
| Hearing Loss, Bilateral | 1 | 2005 | 10 | 0.010 |
Why?
|
| Thiobarbiturates | 1 | 2005 | 5 | 0.010 |
Why?
|
| Blindness | 1 | 2005 | 40 | 0.010 |
Why?
|
| Oscillometry | 1 | 2005 | 25 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2005 | 65 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2010 | 9167 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 1957 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 526 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1805 | 0.010 |
Why?
|
| Intestines | 1 | 2008 | 432 | 0.010 |
Why?
|
| Educational Status | 1 | 2005 | 202 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 2004 | 64 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 671 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 438 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2005 | 203 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 1319 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 611 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2003 | 62 | 0.010 |
Why?
|
| Glycolysis | 1 | 2004 | 191 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 1008 | 0.010 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2003 | 67 | 0.010 |
Why?
|
| Antioxidants | 1 | 2004 | 232 | 0.010 |
Why?
|
| Intracranial Hemorrhages | 1 | 2003 | 136 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2005 | 374 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2004 | 473 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2003 | 288 | 0.010 |
Why?
|
| Receptors, Dopamine | 1 | 2000 | 37 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 423 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2003 | 983 | 0.010 |
Why?
|
| Glutathione | 1 | 2000 | 107 | 0.010 |
Why?
|
| Cell Death | 1 | 2000 | 264 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2001 | 777 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 1827 | 0.010 |
Why?
|